Showing 841 - 860 results of 5,845 for search '(( significant decrease decrease ) OR ( significant ((we decrease) OR (a decrease)) ))~', query time: 0.39s Refine Results
  1. 841

    Specifications of prototypes of RSSCA system. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
  2. 842

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  3. 843

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  4. 844

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  5. 845
  6. 846
  7. 847
  8. 848
  9. 849

    Bacterial strains and plasmids. by Eunsil Choi (8271039)

    Published 2025
    “…This activation altered virulence factors, including reduced biofilm formation, particularly in the 14028Δ<i>bipA</i> strain. Furthermore, the SL1344Δ<i>bipA</i> and 14028Δ<i>bipA</i> strains exhibited significantly decreased swimming motility at 20°C compared to 37°C, confirmed by microscopic observation showing fewer flagella at 20°C. …”
  10. 850

    Enhanced Cell Proliferation and Maturation Using Carboxylated Bacterial Nanocellulose Scaffolds for 3D Cell Culture by Elizabeth Mavil-Guerrero (20833989)

    Published 2025
    “…This interface must possess suitable surface chemistry, biomechanical properties, and fibrillar morphology across nano- to microscale levels to support cell attachment and growth, enabling a biomimetic arrangement. In this study, we developed a hydrogel scaffold made from bacterial nanocellulose (BNC) functionalized with carboxylic acid groups (BNC–COOH) through a reactive deep eutectic solvent (DES), offering a sustainable approach. …”
  11. 851

    Enhanced Cell Proliferation and Maturation Using Carboxylated Bacterial Nanocellulose Scaffolds for 3D Cell Culture by Elizabeth Mavil-Guerrero (20833989)

    Published 2025
    “…This interface must possess suitable surface chemistry, biomechanical properties, and fibrillar morphology across nano- to microscale levels to support cell attachment and growth, enabling a biomimetic arrangement. In this study, we developed a hydrogel scaffold made from bacterial nanocellulose (BNC) functionalized with carboxylic acid groups (BNC–COOH) through a reactive deep eutectic solvent (DES), offering a sustainable approach. …”
  12. 852

    Enhanced Cell Proliferation and Maturation Using Carboxylated Bacterial Nanocellulose Scaffolds for 3D Cell Culture by Elizabeth Mavil-Guerrero (20833989)

    Published 2025
    “…This interface must possess suitable surface chemistry, biomechanical properties, and fibrillar morphology across nano- to microscale levels to support cell attachment and growth, enabling a biomimetic arrangement. In this study, we developed a hydrogel scaffold made from bacterial nanocellulose (BNC) functionalized with carboxylic acid groups (BNC–COOH) through a reactive deep eutectic solvent (DES), offering a sustainable approach. …”
  13. 853
  14. 854

    MXene-Coated Liquid Metal Nanodroplet Aggregates by Mason Zadan (8667870)

    Published 2025
    “…In this work, we show that coating nanoscale droplets of eutectic gallium–indium (EGaIn) LM with small volume fractions of Ti<sub>3</sub>C<sub>2</sub>T<sub><i>x</i></sub> MXenes (0.25 vol %) results in a unique LM morphology in which droplets self-assemble to form semisolid aggregates. …”
  15. 855

    MXene-Coated Liquid Metal Nanodroplet Aggregates by Mason Zadan (8667870)

    Published 2025
    “…In this work, we show that coating nanoscale droplets of eutectic gallium–indium (EGaIn) LM with small volume fractions of Ti<sub>3</sub>C<sub>2</sub>T<sub><i>x</i></sub> MXenes (0.25 vol %) results in a unique LM morphology in which droplets self-assemble to form semisolid aggregates. …”
  16. 856

    Baseline characteristics of the participants. by Junichi Kushioka (12236447)

    Published 2024
    “…This significantly improves patient outcomes and marks a crucial advancement in digital health, addressing key challenges in management and care of LS.…”
  17. 857

    Internal validation by cross-validation. by Junichi Kushioka (12236447)

    Published 2024
    “…This significantly improves patient outcomes and marks a crucial advancement in digital health, addressing key challenges in management and care of LS.…”
  18. 858

    MXene-Coated Liquid Metal Nanodroplet Aggregates by Mason Zadan (8667870)

    Published 2025
    “…In this work, we show that coating nanoscale droplets of eutectic gallium–indium (EGaIn) LM with small volume fractions of Ti<sub>3</sub>C<sub>2</sub>T<sub><i>x</i></sub> MXenes (0.25 vol %) results in a unique LM morphology in which droplets self-assemble to form semisolid aggregates. …”
  19. 859

    Flow chart of inclusion and exclusion criteria. by Ho Geol Woo (7180775)

    Published 2025
    “…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”
  20. 860

    Baseline characteristics of study participants. by Ho Geol Woo (7180775)

    Published 2025
    “…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”